GSK Publishes Q3 2026 Results Call Transcript
Bitget2026/10/29 13:41- GSK held its third-quarter 2026 results call October 28, attended by CEO Luke Miels, CFO Julie Brown, Tony Wood and Nina Mojas.
- Sales rose 5% to £8.9 billion at constant exchange rates; core operating profit increased 5%.
- Management reaffirmed full-year guidance, expecting sales and core operating profit in the upper half of their ranges.
- Restructuring charges could reach £1 billion this year; Brown indicated 2027 interest costs of £900 million to £1 billion.
- Four-monthly HIV prevention data remain under analysis, with regulatory submission expected before year-end; management maintained there was no read-through to treatment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
